Showing results (21-30 of 352) with videos related to

Sort By:
Pageof 36
F1000Research|September 1, 2020
Prediction of local COVID-19 spread in HeidelbergLisa Koeppel, Claudius Gottschalk, Andreas Welker, et al.
Pathogens (Basel, Switzerland)|January 8, 2025
Strategies to Enhance Diagnostic Capabilities for the New Drug-Resistant Tuberculosis (DR-TB) DrugsAntonia Morita Iswari Saktiawati, Anca Vasiliu, Francesca Saluzzo, et al.
International Journal of Mycobacteriology|January 21, 2016
Alteration of human macrophages microRNA expression profile upon infection with Mycobacterium tuberculosisLucinda Furci, Elisa Schena, Paolo Miotto, et al.
The New Microbiologica|May 21, 2013
Tuberculosis: lights and shadows in the current diagnostic landscapeLuca Norbis, Paolo Miotto, Riccardo Alagna, et al.
The Journal of Infectious Diseases|March 14, 2015
Potential market for novel tuberculosis diagnostics: worth the investment?Sandra V Kik, Claudia M Denkinger, Carole Jefferson, et al.
The European Respiratory Journal|August 29, 2020
Diagnostic accuracy of centralised assays for TB detection and detection of resistance to rifampicin and isoniazid: a systematic review and meta-analysisMikashmi Kohli, Emily MacLean, Madhukar Pai, et al.
BMJ Paediatrics Open|October 26, 2021
Experiences with opt-in, at-home screening for SARS-CoV-2 at a primary school in Germany: an implementation studyJonas Wachinger, Maximilian Schirmer, Nicole Täuber, et al.
Microbiology Spectrum|August 18, 2021
Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid TreatmentPatrick Howlett, Pamela Nabeta, Nestan Tukvadze, et al.
Plos Medicine|December 15, 2017
Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling studyEmily A Kendall, Samuel G Schumacher, Claudia M Denkinger, et al.
Pathogens & Immunity|February 21, 2017
Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low IncidenceChristoph Lange, Anna M Mandalakas, Barbara Kalsdorf, et al.
Pageof 36